Guangzhou Boji Medical Biotechnological co., Ltd (Boji for short) was founded in 1998 and restructured in 2002. The current registered capital is more than 10 million US dollars. Boji is the earliest registered and the most experiential CRO in China. Boji is a hightech enterprise which provides full services including regulatory affairs, preclinical research, clinical trials I~IV, PMS, clinical trial for medical devices, data management & biostatistics, SMO etc.
With more than 10year development, Boji now has 6 subsidiaries,25 local offices in China, and several overseas offices. Boji occupies the leading position of Chinese CRO industry in its achievement, profession standard, company size and revenue.
Since its foundation, Boji has provided more than 700 professional services in different medical study phases for about 400 enterprises:
ü About 400 clinical trials (phase I-V, PMS and medical devices)
ü Over 300 pre-clinical researches (pharmacy, PD and PK,toxicology
research)Boji has helped our clients get:
ü More than 30 clinical trial authorizations (CTA)
ü More than 60 new drug certificates
ü About 100 drug manufacturing certificates (a drug approval number)
What We Think
Mission: Let your medical and pharmaceutical achievements better serve the whole world
Vision： Become the World first-class CRO
Value: Integrity Honesty Professional Authority